
Shenzhen YHLO Biotech Co Investor Relations Material
Latest events

Q2 2025
26 Aug, 2025

Q4 2024
25 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Shenzhen YHLO Biotech Co
Access all reports
Shenzhen YHLO Biotech Co., Ltd., founded in 2008, is a Chinese company primarily focused on the research, development, manufacture, and sale of in-vitro diagnostic equipment and supporting reagents. The company's extensive product portfolio includes instruments and reagents based on chemiluminescence immunoassay, immunoblotting, enzyme-linked immunoassay, and immunofluorescence chromatography. These products are used in various medical fields, including autoimmunity, reproductive health, diabetes, and infectious diseases. The company is headquartered in Shenzhen, China, and its shares are listed on the Shanghai Stock Exchange.
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
688575
Country
🇨🇳 China